Cellosaurus Melligen (CVCL_HA63)
| Cell line name | Melligen |
|---|---|
| Accession | CVCL_HA63 |
| Resource Identification Initiative | To cite this cell line use: Melligen (RRID:CVCL_HA63) |
| Comments | Group: Patented cell line. Population: Japanese. Characteristics: Produces insulin in response to extracellular glucose levels that are equivalent to physiological glucose levels. Characteristics: When transplanted into diabetic immunoincompetent mice, Melligen cells restore normoglycemia. Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4195; GCK. Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS. Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Derived from site: In situ; Liver; UBERON=UBERON_0002107. |
| Sequence variations |
|
| Disease | Adult hepatocellular carcinoma (NCIt: C7956) Adult hepatocellular carcinoma (ORDO: Orphanet_210159) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_HA62 (HUH7-ins) |
| Sex of cell | Male |
| Age at sampling | 57Y |
| Category | Cancer cell line |
| Web pages | Info; -; -; https://www.diabetes.co.uk/forum/threads/potential-type-1-diabetes-treatment-receives-us-patent-approval.102547/ |
| Publications | PubMed=26029722; DOI=10.1038/mtm.2015.11; PMCID=PMC4445011 Patent=US10738285 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_HA63 |
| Encyclopedic resources | Wikidata; Q54905184 |
| Entry history | |
| Entry creation | 26-Sep-2016 |
| Last entry update | 14-Aug-2025 |
| Version number | 18 |